Skip to content

Clinical trials

Phase 2/3 trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Taiwan Clear all

189 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20054
20062
20079
20085
20099
20107
20116
201212
20135
20147
20157
201610
20177
201810
201912
20209
202110
202215
20237
202410
202514
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Unknown status35
Recruiting30
Terminated20
Active, not recruiting20
Not yet recruiting3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital15
National Taiwan University Hospital15
AbbVie8
AstraZeneca5
Bristol-Myers Squibb5
Hoffmann-La Roche5
Janssen Research & Development, LLC5
Pfizer5
Taichung Veterans General Hospital5
National Cheng-Kung University Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung13
Neoplasms7
Colitis, Ulcerative6
Neoplasm Metastasis6
Schizophrenia6
Stomach Neoplasms6
Lung Neoplasms5
Breast Neoplasms4
Coronary Artery Disease4
Diabetes Mellitus, Type 24

Trials

Showing 51 to 75 of 189. Each trial links to its page on Pharma Observatory.

89 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.